| QUICK SEARCH |
| Thompson Cancer Survival Center |
|
Home Directions Map Employment Thompson West Thompson Methodist Virtual Tours Contact Us |
| COVENANT HEALTH LINKS |
|
Covenant Home Hospitals & Services Events & Classes Employment Find a Physician Website Map |
| MANAGING YOUR HEALTH |
|
Healthlines / Healthwise Health Information Library Health Advisor Series |
|
TCSC < Thompson Cancer Survival Center at Methodist
| STAR Clinical Trials |
||
Methodist Medical Center of Oak Ridge is recruiting women to participate in the Study of Tamoxifen and Raloxifene (STAR), conducted by the National Surgical Adjuvant Breast and Bowel Project (NSABP) through Thompson Cancer Survival Center in Knoxville, TN.The study involves women age 35 or older who have a high risk of getting breast cancer, based on such factors as whether or not they have had children, a breast biopsy, or a case of breast cancer in their immediate family. "The STAR breast cancer prevention trial is a positive and proactive approach for women at high risk for breast cancer," said Brenda Morris, R.N., clinical trials manager at Thompson Cancer Survival Center at Methodist. "However, the first step is determining if indeed you are at high risk. This is a simple assessment that can be done over the phone." Participants from Methodist's service area area, primarily Anderson, Roane, Morgan, Campbell and Scott counties, may have their required medical tests and exams at Methodist Medical Center. "We are very pleased to be able to offer a clinic in Oak Ridge for women from the surrounding area," said Jamie Rodgers Breeden, R.N., STAR coordinator. "This provides a more convenient location for women to participate in the STAR breast cancer prevention trial." The purpose of STAR is to determine whether the drug raloxifene is as effective or more effective than tamoxifen in preventing breast cancer in women that are at high risk. Raloxifene has been approved by the Federal Drug Administration (FDA) for the prevention of osteoporosis, and tamoxifen is FDA approved for the reduction of risk of developing breast cancer in high risk women. The study involves 23,000 postmenopausal women who make at least a seven-year commitment to participate (including five years of medication), breast examinations every six months, and an annual laboratory analysis at no charge to the participant. Follow-up examinations, including mammograms, physical examinations and gynocologic examinations must be done on a regular basis for the remainder of the participant's life.
To find out if you might be eligible for the STAR trial, call (865) 481-1664. |
Covenant Health | All About Us
Thompson Cancer Survival Center Home